Aytu BioPharma
AYTU | NASDAQ
$1.82
+$0.04 (+2.25%)
At close: Nov 16, 2026, 4:00 PM ET
$2.62
+$0.80 (+43.97%)
After-hours:
Nov 16, 2026, 7:59 PM ET
+2.25%
(1D)No price chart data available for 1D timeframe.
Rating
41.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #474/1021 (Top 46%)
Key Statistics
Market Data
Market Cap $22.42M
1D Range
1.75 1.87
52W Range
1.75 2.90
Valuation (TTM)
PE -1.10
PB 0.64
EV/EBITDA -1.68
Valuation (NTM)
Forward PE 117.50
Forward PEG 0.03
Price Target $15.00
Cash Flow
FCF Yield 14.5%
SBC Adj. FCF Yield 11.4%
SBC Impact -21.3%
Margins
Gross Margin 64.0%
Operating Margin -14.4%
FCF Margin 5.7%
Growth (CAGR)
Revenue 3Y | 5Y -18.8% |
-2.6%
Dil EPS 3Y | 5Y 24.7% |
97.4%
FCF 3Y | 5Y 1183.1% |
97.0%
Returns
ROA -13.6%
ROE -52.9%
ROIC -14.2%
Financial Health
Net Cash
$9.06M
Current Ratio 1.13
Interest Coverage -7.36
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international m...
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 16, 2026
EPS
-$0.2
Beat +22.08%
YoY:
-150.00% REV
$14.84M
Beat +11.84%
YoY:
+6.87%Next Earnings
Feb 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$15.00
Upside
+724.18%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AYTU